Shenzhen-based QuantumPharm Inc., operating under the name Xtalpi Inc. (HKG: 2228), has announced a strategic partnership with US-based Amazon Web Services (AWS). AWS will serve as Xtalpi’s cloud service provider, empowering the company to enhance its innovative development in life science, chemistry, and new materials through the use of artificial intelligence (AI), quantum physics, and robotics, among other advanced technologies.
AWS’s Comprehensive Service Portfolio
AWS has been expanding its service offerings, now boasting over 240 full-function services that span a range of critical areas including computing, storage, databases, networks, data analysis, machine learning, and AI. This comprehensive portfolio positions AWS as a key player in supporting the digital transformation and technological advancement of various industries, including life sciences.
Boosting Innovation in Life Sciences and Beyond
The partnership with Xtalpi Inc. signifies AWS’s commitment to the life sciences sector, providing Xtalpi with the tools necessary to drive innovation in life science, chemistry, and material science research. By leveraging AWS’s cloud services, Xtalpi Inc. is poised to make significant strides in AI-driven drug discovery, quantum physics applications, and robotics, furthering the development of cutting-edge solutions in these fields.-Fineline Info & Tech
